AI & Tech Brief — June 18, 2026
OpenAI's AI chemist achieved a breakthrough in drug-making chemistry using GPT-5.4, while the company also launched LifeSciBench to measure how well AI systems handle real-world life science research [2][3]. Meanwhile, industry debate intensifies over AI's role in e-commerce and the challenges of building safer AI systems [1][4].
Read full analysis →